Endogenous and non-endogenous versions of human G protein-coupled receptors
First Claim
Patent Images
1. An isolated polynucleotide encoding a non-endogenous, constitutively activated version of a wild-type G protein-coupled receptor, wherein the wild-type G protein-coupled receptor comprises SEQ. ID.:
- 16 and wherein said non-endogenous constitutively activated version contains a mutation of an amino acid residue located 16 amino acid residues from a proline residue in TM6.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention disclosed in this patent document relates to transmembrane receptors, more particularly to a human G protein-coupled receptor and to mutated (non-endogenous) versions of the human GPCRs for evidence of constitutive activity.
-
Citations
8 Claims
-
1. An isolated polynucleotide encoding a non-endogenous, constitutively activated version of a wild-type G protein-coupled receptor, wherein the wild-type G protein-coupled receptor comprises SEQ. ID.:
- 16 and wherein said non-endogenous constitutively activated version contains a mutation of an amino acid residue located 16 amino acid residues from a proline residue in TM6.
- View Dependent Claims (4, 5, 6, 7, 8)
-
2. An isolated polynucleotide encoding a non-endogenous, constitutively activated version of a wild-type G protein-coupled receptor, wherein the wild-type G protein-coupled receptor comprises SEQ. ID. NO.:
- 16, and wherein said polynucleotide encodes an amino avid sequence that comprises.
- View Dependent Claims (3)
Specification